Literature DB >> 2773661

Effects of amrinone on twitch, tetanus and shortening kinetics in mammalian skeletal muscle.

A Månsson1, J Mörner, K A Edman.   

Abstract

The contractile effects of amrinone were studied on twitch and tetanus responses of mouse lumbrical muscles. Amrinone (1.1 mM) increased the maximum force level during the tetanus, reduced the rate of rise of force during the onset of tetanus and prolonged the time from the last stimulus to half-relaxation. The rate of redevelopment of force after a release during the tetanus plateau was likewise reduced. Amrinone (greater than or equal to 0.5 mM) increased the time to peak twitch force and the time to half-relaxation during the twitch. The peak twitch force was not significantly changed. The force-velocity relation was markedly affected by amrinone: there was a decrease in maximum velocity of shortening, an increase in maximum isometric force and a decrease in curvature of the force-velocity relation. The results suggest that amrinone modulates the kinetic properties of the myosin cross-bridges by exerting a specific effect upon the myofilament system. The latter effects are mainly responsible for the contractile changes produced by amrinone in mouse skeletal muscle. Amrinone appears to have little effect on the metabolism of activator calcium in this particular preparation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773661     DOI: 10.1111/j.1748-1716.1989.tb08627.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  10 in total

1.  Nonlinear cross-bridge elasticity and post-power-stroke events in fast skeletal muscle actomyosin.

Authors:  Malin Persson; Elina Bengtsson; Lasse ten Siethoff; Alf Månsson
Journal:  Biophys J       Date:  2013-10-15       Impact factor: 4.033

2.  Actomyosin-ADP states, interhead cooperativity, and the force-velocity relation of skeletal muscle.

Authors:  Alf Månsson
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

3.  Effects of amrinone on shortening velocity and force development in skinned skeletal muscle fibres.

Authors:  R Bottinelli; V Cappelli; S E Morner; C Reggiani
Journal:  J Muscle Res Cell Motil       Date:  1993-02       Impact factor: 2.698

4.  Actomyosin based contraction: one mechanokinetic model from single molecules to muscle?

Authors:  Alf Månsson
Journal:  J Muscle Res Cell Motil       Date:  2016-11-18       Impact factor: 2.698

5.  Comparing models with one versus multiple myosin-binding sites per actin target zone: The power of simplicity.

Authors:  Alf Månsson
Journal:  J Gen Physiol       Date:  2019-03-14       Impact factor: 4.086

6.  Hypothesis: Single Actomyosin Properties Account for Ensemble Behavior in Active Muscle Shortening and Isometric Contraction.

Authors:  Alf Månsson
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

7.  Drug effect unveils inter-head cooperativity and strain-dependent ADP release in fast skeletal actomyosin.

Authors:  Nuria Albet-Torres; Marieke J Bloemink; Tom Barman; Robin Candau; Kerstin Frölander; Michael A Geeves; Kerstin Golker; Christian Herrmann; Corinne Lionne; Claudia Piperio; Stephan Schmitz; Claudia Veigel; Alf Månsson
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

8.  Potentiation in mouse lumbrical muscle without myosin light chain phosphorylation: is resting calcium responsible?

Authors:  Ian C Smith; William Gittings; Jian Huang; Elliott M McMillan; Joe Quadrilatero; A Russell Tupling; Rene Vandenboom
Journal:  J Gen Physiol       Date:  2013-02-11       Impact factor: 4.086

9.  Nonlinear Actomyosin Elasticity in Muscle?

Authors:  Alf Månsson; Malin Persson; Nabil Shalabi; Dilson E Rassier
Journal:  Biophys J       Date:  2018-12-13       Impact factor: 4.033

10.  The effects of inorganic phosphate on muscle force development and energetics: challenges in modelling related to experimental uncertainties.

Authors:  Alf Månsson
Journal:  J Muscle Res Cell Motil       Date:  2019-10-16       Impact factor: 2.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.